Evidence map›Paper›PMID 35521800›Full record

ArticleThe Journal of clinical endocrinology and metabolism2022

Timing of Puberty, Pubertal Growth, and Adult Height in Short Children Born Small for Gestational Age Treated With Growth Hormone.

Emmie N Upners, Lars Lau Raket, Jørgen H Petersen, Ajay Thankamony, Edna Roche, Guftar Shaikh, Jeremy Kirk, Hilary Hoey, Sten-A Ivarsson, Olle Söder and 2 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Growth Hormone Treatment for Non-GHD Disorders: Excitement Tempered by Biology.The Journal of clinical endocrinology and metabolism · 2024
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Emmie N UpnersDepartment of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-7843-7590
Lars Lau RaketDepartment of Clinical Sciences, Lund University, Lund, Sweden.
Jørgen H PetersenDepartment of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Ajay ThankamonyDepartment of Pediatrics, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.
Edna RocheDepartment of Pediatrics, CHI at Tallaght University Hospital, Trinity College Dublin, The University of Dublin, Dublin 24, Ireland.ORCID 0000-0001-7266-8649
Guftar ShaikhDepartment of Endocrinology, Royal Hospital for Children, Glasgow G51 4TF, UK.
Jeremy KirkDepartment of Endocrinology, Birmingham Children's Hospital, Birmingham B4 6NH, UK.ORCID 0000-0002-7183-7727
Hilary HoeyDepartment of Pediatrics, CHI at Tallaght University Hospital, Trinity College Dublin, The University of Dublin, Dublin 24, Ireland.ORCID 0000-0002-7618-1659
Sten-A IvarssonDepartment of Clinical Sciences, Endocrine and Diabetes Unit, University of Lund, 22100 Lund, Sweden.
Olle SöderPediatric Endocrinology Unit, Department of Women's and Children's Health, Karolinska Institute, 17177 Stockholm, Sweden.
Anders JuulDepartment of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-0534-4350
Rikke Beck JensenDepartment of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-4522-672X

Funding

Candy Foundation 2017-224Novo Nordisk
6 · The paper itself

Abstract

contextGrowth hormone (GH) is used to treat short children born small for gestational age (SGA); however, the effects of treatment on pubertal timing and adult height are rarely studied.

objectiveTo evaluate adult height and peak height velocity in short GH-treated SGA children.

methodsProspective longitudinal multicenter study. Participants were short children born SGA treated with GH therapy (n = 102). Adult height was reported in 47 children. A reference cohort of Danish children was used. Main outcome measures were adult height, peak height velocity, age at peak height, and pubertal onset. Pubertal onset was converted to SD score (SDS) using Danish reference data.

resultsGain in height SDS from start of treatment until adult height was significant in both girls (0.94 [0.75; 1.53] SDS, P = .02) and boys (1.57 [1.13; 2.15] SDS, P < .001). No difference in adult height between GH dosage groups was observed. Peak height velocity was lower than a reference cohort for girls (6.5 [5.9; 7.6] cm/year vs 7.9 [7.4; 8.5] cm/year, P < .001) and boys (9.5 [8.4; 10.7] cm/year vs 10.1 [9.7; 10.7] cm/year, P = .002), but no difference in age at peak height velocity was seen. Puberty onset was earlier in SGA boys than a reference cohort (1.06 [-0.03; 1.96] SDS vs 0 SDS, P = .002) but not in girls (0.38 [-0.19; 1.05] SDS vs 0 SDS, P = .18).

conclusionGH treatment improved adult height. Peak height velocity was reduced, but age at peak height velocity did not differ compared with the reference cohort. SGA boys had an earlier pubertal onset compared with the reference cohort.

Indexed as

Body HeightGrowth DisordersHuman Growth HormoneInfant, Small for Gestational AgePubertyAdultChildFemaleGestational AgeHumansInfant, NewbornMaleProspective StudiesTime FactorsHuman Growth Hormoneadult heightGH treatmentpeak height velocitypubertySGA

Identifiers

PMID35521800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.